You are here

Article info

Article menu

Download PDFPDF

Therapeutics/Prevention
Randomised controlled trial
ABT-450/r-ombitasvir and dasabuvir with ribavirin eliminates viraemia in most patients with HCV infection with cirrhosis
Free

Authors

  • Valérie Martel-Laferrière Microbiologie et Maladies Infectieuses, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to : Dr Valérie Martel-Laferrière, Microbiologie et Maladies Infectieuses, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, 1058 rue Saint-Denis, Montréal, Québec, Canada H2X 3J4; valerie.martel-laferriere{at}umontreal.ca
View Full Text

Citation

Martel-Laferrière V
ABT-450/r-ombitasvir and dasabuvir with ribavirin eliminates viraemia in most patients with HCV infection with cirrhosis
BMJ Evidence-Based Medicine 2015;20:6.

Publication history

  • First published September 10, 2014.
Online issue publication 
October 26, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions